首页> 外文OA文献 >Interprovincial spoke-to-hub transport using the Impella Recover LP 5.0 left ventricular assist device as a bridge to long-term circulatory support
【2h】

Interprovincial spoke-to-hub transport using the Impella Recover LP 5.0 left ventricular assist device as a bridge to long-term circulatory support

机译:使用Impella Recover LP 5.0左心室辅助设备进行省际辐条到枢纽的运输,以此作为长期循环支持的桥梁

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Current hospital administrative practices categorize health care centres in a network of ‘spokes’ (primary care centres) and ‘hubs’ (tertiary care centres). For the treatment of cardiogenic shock, long-term left ventricular assist devices (LVADs) and transplant therapies are only used at a few hub centres nationwide and are, thus, only available to patients living in close proximity to these centres. The relatively lower technical requirements of the Impella Recover LP 5.0 LVAD (ABIOMED Inc, USA) translate into greater use by spoke centres for the short-term treatment of cardiogenic shock, and facilitate appropriate stabilization and subsequent transportation to a suitable hub centre. Based on a review of the literature, the present report describes the first case demonstrating successful use of the Impella Recover LP 5.0 LVAD, implanted under local anesthetic, for the purposes of interprovincial spoke-to-hub transport in a bridge-to-bridge-to-transplant procedure. By providing an economical and technically straightforward alternative to traditional extracorporeal membrane oxygenation, the present case demonstrates that less invasive LVADs are valuable to the spoke-and-hub model for delivery of specialized cardiac care.
机译:当前的医院管理实践将医疗中心分类为“辐条”(主要医疗中心)和“中心”(三级医疗中心)网络。对于心源性休克的治疗,长期的左心室辅助装置(LVAD)和移植疗法仅在全国一些枢纽中心使用,因此仅适用于住在这些中心附近的患者。 Impella Recover LP 5.0 LVAD(美国ABIOMED Inc)的相对较低的技术要求转化为辐条中心更多地用于心源性休克的短期治疗,并有助于适当的稳定和随后的运输到合适的枢纽中心。基于对文献的回顾,本报告描述了第一个案例,该案例展示了在局麻下成功植入Impella Recover LP 5.0 LVAD的目的,目的是实现跨省跨桥到跨桥的跨省运输。移植程序。通过为传统的体外膜氧合作用提供经济且技术上简单的替代方法,本案例证明了侵入性较低的LVAD对轮辐和枢纽模型的价值在于提供专业的心脏护理。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号